SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes
Reported from TCT 2021
TCT 2021: Luis Ortega Paz interviews Rafael Romaguera, principal investigator of the SUGAR trial. SUGAR is the first powered trial to compare new generation DES in patients with diabetes, and also the first to include a broad population of patients with diabetes (all-comers design). It was funded by the Spanish Society of Cardiology.
Authors
No comments yet!